213 related articles for article (PubMed ID: 9669691)
1. Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukemia.
Montoto S; Bosch F; Estrach T; Blade J; Nomdedeu B; Nontserrat E
Leuk Lymphoma; 1998 Jun; 30(1-2):199-202. PubMed ID: 9669691
[TBL] [Abstract][Full Text] [Related]
2. Pyoderma gangrenosum with liver, spleen and bone involvement in a patient with chronic myelomonocytic leukaemia.
Vadillo M; Jucgla A; Podzamczer D; Rufi G; Domingo A
Br J Dermatol; 1999 Sep; 141(3):541-3. PubMed ID: 10583064
[TBL] [Abstract][Full Text] [Related]
3. Imatinib-induced pyoderma gangrenosum in a patient with chronic myeloid leukemia.
Faraci AG; Genovese G; Ferrucci S; Marzano AV
Indian J Dermatol Venereol Leprol; 2021; 87(5):704-706. PubMed ID: 34114414
[No Abstract] [Full Text] [Related]
4. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.
Yurci A; Guven K; Torun E; Gursoy S; Baskol M; Akgun H; Ozbakir O; Yucesoy M
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):811-5. PubMed ID: 17700270
[TBL] [Abstract][Full Text] [Related]
5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
6. Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin.
de Zwaan SE; Iland HJ; Damian DL
Australas J Dermatol; 2009 Feb; 50(1):56-9. PubMed ID: 19178495
[TBL] [Abstract][Full Text] [Related]
7. [A bad cae of pyoderma gangrenosum].
Dupont-Creteur C; Carpentier O; Delaporte E
Rev Med Interne; 2002 May; 23(5):474-5. PubMed ID: 12064221
[No Abstract] [Full Text] [Related]
8. Pyoderma gangrenosum associated with biphenotypic acute leukemia.
Asai M; Aragane Y; Kawada A; Shimada T; Kanamaru A; Yamada H; Tezukam T
J Am Acad Dermatol; 2001 Mar; 44(3):530-1. PubMed ID: 11209130
[TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders.
Beretta L; Caronni M; Vanoli M; Scorza R
Br J Dermatol; 2002 Aug; 147(2):385-6. PubMed ID: 12174121
[No Abstract] [Full Text] [Related]
10. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
11. Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response.
Koskenvesa P; Kreutzman A; Rohon P; Pihlman M; Vakkila E; Räsänen A; Vapaatalo M; Remes K; Lundán T; Hjorth-Hansen H; Vakkila J; Simonsson B; Mustjoki S; Porkka K
Eur J Haematol; 2014; 92(5):413-20. PubMed ID: 24372965
[TBL] [Abstract][Full Text] [Related]
12. [A no scarring persistent skin lesion for 3 years pyoderma gangrenosum].
Ndour MA; Sow D; Diedhiou D; Senghor F; Diembou M; Diouf M; Faye A; Diallo IM; Barrage AL; Kabou LM; Mbaye MN; Sarr A
Pan Afr Med J; 2019; 32():198. PubMed ID: 31312310
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary pyoderma gangrenosum without cutaneous manifestations.
Sakata KK; Penupolu S; Colby TV; Gotway MB; Wesselius LJ
Clin Respir J; 2016 Jul; 10(4):508-11. PubMed ID: 25354722
[TBL] [Abstract][Full Text] [Related]
14. Pyoderma gangrenosum due to lenalidomide use for multiple myeloma.
Dasanu CA; Bockorny B; Alexandrescu DT
J Oncol Pharm Pract; 2015 Dec; 21(6):471-3. PubMed ID: 24986794
[TBL] [Abstract][Full Text] [Related]
15. Bilateral peripheral ulcerative keratitis associated with pyoderma gangrenosum.
Bouchard CS; Meyer MA; McDonnell JF
Cornea; 1997 Jul; 16(4):480-2. PubMed ID: 9220248
[TBL] [Abstract][Full Text] [Related]
16. Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
Krauze E; Brzezińska-Wcisło L; Kamińska-Winciorek G; Wygledowska-Kania M; Sygula E
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):589-92. PubMed ID: 16164714
[TBL] [Abstract][Full Text] [Related]
17. Rare association of pyoderma gangrenosum and palmoplantar pustulosis: a case report and review of the previous works.
Ohtsuka M; Yamamoto T
J Dermatol; 2014 Aug; 41(8):732-5. PubMed ID: 24986043
[TBL] [Abstract][Full Text] [Related]
18. Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study.
Michallet M; Maloisel F; Delain M; Hellmann A; Rosas A; Silver RT; Tendler C;
Leukemia; 2004 Feb; 18(2):309-15. PubMed ID: 14671645
[TBL] [Abstract][Full Text] [Related]
19. Pyoderma gangrenosum in an infant: A case report and review of the literature.
Crouse L; McShane D; Morrell DS; Wu EY
Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.
Wu BC; Patel ED; Ortega-Loayza AG
Br J Dermatol; 2017 Jul; 177(1):72-83. PubMed ID: 27864925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
